Systematic Review of the Use of Multiperson Activity Schedules for Individuals With Disabilities
Digital Commons - USU (Utah State University) · 01.05.2024
DOI: 10.26076/1f61-975c ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Digital Commons - USU (Utah State University), erschienen am 01.05.2024. Verfasst von Caili Johnson.
Abstract (Originalsprache)
Multiperson activity schedules capitalize on the benefits of independent activity schedules, a commonly used visual support for individuals with disabilities. Activity schedules minimize the need for adult prompting and increase independence with complex tasks by breaking them down into pictures, written words, or videos. Multiperson schedules allow pairs and small groups of individuals with disabilities to work together with minimal adult involvement to accomplish a task. This systematic review aims to inform researchers and other interested persons regarding the use of multiperson activity schedules to aid in decision-making and support implementation. We screened 146 articles and dissertations against our study inclusion criteria and found 11 studies meeting the criteria. Data compiled from the 11 studies highlight the usefulness and effectiveness of this evolving intervention. Strengths and weaknesses of the included studies are discussed, as well as implications for future research and practice.
Schlagwörter
Zitieren
APA
Johnson, C. (2024). Systematic Review of the Use of Multiperson Activity Schedules for Individuals With Disabilities. Digital Commons - USU (Utah State University). https://doi.org/10.26076/1f61-975c
Vancouver
Johnson C. Systematic Review of the Use of Multiperson Activity Schedules for Individuals With Disabilities. Digital Commons - USU (Utah State University). 2024. doi:10.26076/1f61-975c
BibTeX
@article{Johnson2024,
author = {Johnson, Caili},
title = {Systematic Review of the Use of Multiperson Activity Schedules for Individuals With Disabilities},
journal = {Digital Commons - USU (Utah State University)},
year = {2024},
doi = {10.26076/1f61-975c}
}
EUVIMED